Cambridge Investment Research Advisors, Inc. Ionis Pharmaceuticals Inc Transaction History

Cambridge Investment Research Advisors, Inc.

$29.4 Billion
Q3 2024

A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 9,738 shares of IONS stock, worth $353,781. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,738

Previous 10,048 3.09%

Holding current value

$353,781

Previous $479,000 18.58%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$40.06 - $51.86 $12,418 - $16,076	-310 Reduced 3.09%	9,738 $390,000
Q2 2024 Jul 26, 2024	BUY	$36.45 - $47.7 $26,827 - $35,107	736 Added 7.9%	10,048 $479,000
Q1 2024 Apr 24, 2024	SELL	$42.03 - $53.55 $72,375 - $92,213	-1,722 Reduced 15.61%	9,312 $404,000
Q4 2023 Feb 09, 2024	BUY	$43.39 - $51.63 $190,351 - $226,500	4,387 Added 66.0%	11,034 $558,000
Q3 2023 Oct 24, 2023	SELL	$38.5 - $47.13 $31,839 - $38,976	-827 Reduced 11.07%	6,647 $302,000
Q2 2023 Jul 13, 2023	SELL	$34.73 - $43.33 $34,730 - $43,330	-1,000 Reduced 11.8%	7,474 $307,000
Q1 2023 May 11, 2023	SELL	$33.58 - $41.2 $36,299 - $44,537	-1,081 Reduced 11.31%	8,474 $303,000
Q4 2022 Feb 08, 2023	SELL	$37.12 - $46.52 $50,743 - $63,592	-1,367 Reduced 12.52%	9,555 $361,000
Q3 2022 Oct 17, 2022	SELL	$36.54 - $48.66 $7,308 - $9,732	-200 Reduced 1.8%	10,922 $483,000
Q2 2022 Jul 13, 2022	BUY	$31.71 - $43.0 $20,770 - $28,165	655 Added 6.26%	11,122 $411,000
Q1 2022 May 12, 2022	BUY	$29.88 - $37.04 $597 - $740	20 Added 0.19%	10,467 $387,000
Q4 2021 Feb 03, 2022	SELL	$25.61 - $35.1 $164,416 - $225,342	-6,420 Reduced 38.06%	10,447 $317,000
Q3 2021 Nov 02, 2021	SELL	$33.54 - $40.55 $80,730 - $97,603	-2,407 Reduced 12.49%	16,867 $565,000
Q2 2021 Aug 10, 2021	BUY	$34.54 - $47.25 $151,872 - $207,758	4,397 Added 29.56%	19,274 $768,000
Q1 2021 May 07, 2021	BUY	$42.51 - $63.78 $632,421 - $948,855	14,877 New	14,877 $668,000
Q1 2020 May 08, 2020	SELL	$41.6 - $63.4 $156,956 - $239,208	-3,773 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$53.85 - $65.27 $16,424 - $19,907	305 Added 8.79%	3,773 $227,000
Q3 2019 Nov 06, 2019	BUY	$59.06 - $72.15 $236 - $288	4 Added 0.12%	3,468 $207,000
Q2 2019 Aug 15, 2019	SELL	$62.09 - $86.14 $2,918 - $4,048	-47 Reduced 1.34%	3,464 $0
Q1 2019 May 08, 2019	BUY	$52.92 - $81.17 $185,802 - $284,987	3,511 New	3,511 $0
Q4 2018 Feb 05, 2019	SELL	$43.37 - $59.54 $262,171 - $359,919	-6,045 Closed	0 $0
Q3 2018 Nov 02, 2018	BUY	$42.88 - $53.7 $40,693 - $50,961	949 Added 18.62%	6,045 $0
Q2 2018 Aug 10, 2018	BUY	$40.53 - $50.7 $206,540 - $258,367	5,096 New	5,096 $0
Q4 2017 Feb 22, 2018	SELL	$50.3 - $64.39 $245,212 - $313,901	-4,875 Closed	0 $0
Q3 2017 Nov 07, 2017	BUY	$45.56 - $59.57 $23,372 - $30,559	513 Added 11.76%	4,875 $247,000
Q2 2017 Aug 08, 2017	BUY	N/A	4,362	4,362 $222,000

Others Institutions Holding IONS

# of Institutions

402

Shares Held

136M

Call Options Held

862K

Put Options Held

582K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.16B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account

Cambridge Investment Research Advisors, Inc. Ionis Pharmaceuticals Inc Transaction History